The Quick Answer
A GLP-1 weight loss plateau happens when your body adjusts to your current dose and settles at a new set point, which is relatively normal in the treatment process. In the SURMOUNT-1 analysis of tirzepatide, most people reached a weight plateau somewhere between 24 and 36 weeks, and higher doses tended to plateau later.1 Research suggests the most common reasons a stall happens early are being under your target dose, losing muscle instead of fat, or day-to-day habits that have drifted. At Defiant in Lisle, we look at your dose, your body composition scan, and your labs before changing anything.
If the scale has stopped moving on your GLP-1, don't be alarmed. A plateau is a normal, well-documented part of how these medications work, and in most cases it's something your provider can work through. The trick is knowing whether you've hit a real plateau or just a normal weekly wobble, and then adjusting the right lever.
Here's what a stall usually means, why it happens, and how a medically supervised program approaches it.
What a Plateau Actually Is
A plateau is a stretch where your weight holds steady for several weeks even though you're still taking your medication and following your plan. The key word there is several. One flat week, or a two-pound bump after a salty dinner, is not a plateau. Weight moves around daily because of water, sodium, hormones, and where you are in your cycle, so a true plateau is something you only see when you zoom out over three or four weeks of data.
There's also a difference between an expected plateau and an early one. Every GLP-1 has a point where weight loss naturally levels off, usually once you've been on a steady therapeutic dose for a while. In the STEP 1 trial, people taking semaglutide saw their weight loss reach its lowest point around week 60, then hold fairly steady through the end of the study at 68 weeks.2 So if you've been losing steadily for the better part of a year and things slow down, that's your body doing exactly what the research predicts. An early stall, the kind that shows up in month two or three, is usually the more fixable kind, and it's worth a closer look.
Why GLP-1 Weight Loss Stalls
You Haven't Reached Your Effective Dose Yet
This is the big one, and it's the reason we titrate the way we do. GLP-1 medications work on a dose response curve, which means the amount you're taking matters a lot for how much weight you lose. In SURMOUNT-1, weight loss ranged from about 16% on the lower tirzepatide dose all the way up to 22.5% on the highest dose over 72 weeks.3 That same plateau analysis found that people on higher doses tended to keep losing longer before leveling off.1
If you started on an entry dose and your weight loss slowed after a month or two, there's a decent chance you simply haven't climbed to the dose your body responds to yet. That's not a failure. It's the normal part of the process where your provider steps you up.
You're Losing Muscle Along With Fat
When you lose weight quickly, some of what comes off is lean muscle, and muscle is a big part of what keeps your metabolism humming. Lose too much of it and your body burns fewer calories at rest, which can slow everything down and make the scale stick. This is one of the most common reasons a stall sneaks up on people, and it's also the one you can't see on a regular bathroom scale. A scale tells you total pounds. It can't tell you whether those pounds were fat or muscle, which is exactly the number that matters here.
That's why we run a Styku 3D body composition scan at baseline and then monthly. If the scan shows you're dropping lean mass, the fix usually isn't a higher dose. It's protein and resistance training, which brings us to the next point.
Life Got Busy and Some Habits Slipped
GLP-1s are powerful, but they're not working in a vacuum. As your appetite comes back up between doses, or as life gets busy, it's easy for portions to creep, protein to slip, steps to fall off, and sleep to get short. None of these are a moral failing and they happen to almost everyone at some stage. They just add up. A stall is often your body's way of flagging that a couple of the basics need attention again, and small corrections here tend to get things moving without any change to your medication at all.
Your Body Found a New Set Point
Your set point is the weight your body treats as "normal" and tries to defend, a bit like a thermostat set to a certain temperature. Your body genuinely fights to hold onto weight. As you lose, hunger hormones and metabolism shift in ways that defend a lower number, which is part of why obesity is now understood as a chronic condition rather than a willpower problem. A plateau can simply be your body settling at a new set point for a while before the next phase of loss. Sometimes the right move is patience and consistency rather than a change, and a good provider will tell you when that's the case instead of reaching for the dose dial every time.
What We Do When Your Weight Stalls
We look at data, then we adjust one thing at a time so we can actually tell what worked.
The first thing we check is your dose and where you are in the titration schedule. Defiant titrates GLP-1 protocols every two weeks rather than monthly, which is the main way we differ from the fixed-dose telehealth model. Bi-weekly check-ins mean that if you've plateaued because you're under your effective dose, we can step you up sooner and more gradually, which also tends to be easier on your stomach than big monthly jumps. If you want the full picture on how that works, our explainer on the bi-weekly GLP-1 titration schedule walks through it.
Next we look at your most recent body composition scan. If you're losing lean mass, the plan shifts toward protecting muscle: more protein, and structured resistance work through our GLP-1 muscle-preservation training with Britt. Keeping muscle on board is one of the better ways to keep your metabolism working for you while you lose.
We also revisit the basics with you, because they matter more than people expect. Protein at every meal, enough water, consistent movement, and real sleep do a lot of quiet work here. And sometimes we look at whether it's time to consider a different medication. Defiant offers semaglutide and tirzepatide, and the right choice depends on your history, your response so far, and your goals, not on which one is trendy this month.
If your labs haven't been checked in a while, we may revisit those too, since thyroid, blood sugar, and other markers can all play a role in how your body responds. Every protocol starts with a lab review and a body scan for exactly this reason.
- A GLP-1 weight loss plateau is a normal stage of treatment, not a sign the medication stopped working.
- Research suggests most people on tirzepatide plateaued between 24 and 36 weeks, and higher doses plateaued later.
- The most common fixable causes of an early stall are being under your effective dose, losing muscle instead of fat, and habits that have drifted.
- A regular scale can't tell fat loss from muscle loss, which is why body composition scans matter during a plateau.
- Defiant titrates every two weeks and reviews your dose, body scan, and labs before changing your plan.
Frequently Asked Questions
Break the Stall.
Stalls are normal, and they're usually solvable with the right data. If your weight loss has plateaued, a review of your dose, body composition, and labs can point to the real reason and the right next step.
Keep Reading
Last updated July 4, 2026.
References
- Horn DB, et al. Time to weight plateau with tirzepatide treatment in the SURMOUNT-1 and SURMOUNT-4 clinical trials. Clinical Obesity. 2025;15(3):e12734. PubMed
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). New England Journal of Medicine. 2021;384:989-1002. NEJM
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022;387:205-216. NEJM